Ultragenyx Pharmaceutical
RARE
RARE
311 hedge funds and large institutions have $3.68B invested in Ultragenyx Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 111 increasing their positions, 108 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
17% less call options, than puts
Call options by funds: $31.5M | Put options by funds: $37.9M
24% less capital invested
Capital invested by funds: $4.82B → $3.68B (-$1.14B)
Holders
311
Holding in Top 10
5
Calls
$31.5M
Puts
$37.9M
Top Buyers
| 1 | +$37.2M | |
| 2 | +$35.1M | |
| 3 | +$32.4M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
+$32.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$26.3M |
Top Sellers
| 1 | -$84.7M | |
| 2 | -$65.7M | |
| 3 | -$40.7M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$37.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$27.6M |